— Know what they know.
Not Investment Advice

ALPS NASDAQ

Alps Group Inc
1W: -1.0% 1M: -28.1% 3M: -48.0% YTD: -48.7%
$0.47
-0.00 (-0.47%)
 
Weekly Expected Move ±9.8%
$0 $0 $0 $1 $1
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 36 · $77.4M mcap · 166M float · 0.066% daily turnover · Short 14% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$77.4M
52W Range0.445-2.9
Volume52,916
Avg Volume110,387
Beta-0.09
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOSeng Kong Tham
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2025-10-31
Unit E-18-01 & E-18-02, Level 18, Icon Tower (East), No. 1, Jalan 1/68F, Off Jalan Tun Razak
Kuala Lumpur, WP 50400
MY
+1 603 216 31113
About Alps Group Inc

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

Recent Insider Trades

NameTypeSharesPriceDate
Lee Hee Hang 0 2026-04-17
Poh Chit Laa 0 2026-03-18
Chua Boon Ping 0 2026-03-18
Chew Yoke Ling 0 2026-03-18
Cheing Lye-Ping 0 2026-03-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms